Attachment 4 Notifiable Diseases Poster.pdf

measles (rubeola) melioidosis meningitis (specify agent when reporting) meningococcal disease, invasive infections novel in�uenza A virus infections novel respiratory virus infections (SARS, MERS, etc.)

orthopoxvirus infections (i.e., smallpox, mpox) pertussis plague poliomyelitis Q fever rabies (human and animal infections)

Staphylococcus aureus infections with vancomycin MIC ≥ 4 mcg / mL

Shiga-toxin producing E. coli infections (including O157) syphilis

• positive non-treponemal or treponemal test

• during pregnancy

• congenital tuberculosis (TB)

• con�rmed or presumed active TB disease, any age

• latent TB infection (inactive TB) in children <6 tularemia viral hemorrhagic fevers

NOTIFIABLE DISEASE

CONDITION REPORTING

For more information:

www.dph.ga.gov/disease-reporting

REPORT IMMEDIATELY

Call: District Health O�ce or 1-866-PUB-HLTH (1-866-782-4584)

All Georgia physicians, laboratories, and other health care providers are required by law to report patients with the following conditions.

SUBMISSION REQUIREMENTS FOR CLINICAL MATERIALS1

LEGEND

Report cases electronically through the state electronic noti�able disease surveillance system at sendss.state.ga.us

All reported cases Send invasive2 specimens Hold 7 days and submit if DPH requests

DPH does not routinely test but submission may occur upon DPH approval all outbreaks/clusters (including infectious and non-infectious causes, toxic substance and drug-related, and any other outbreak) unusual occurrence of disease of public health concern all acute arboviral infections

• California serogroup viruses (California encephalitis, Jamestown Canyon, keystone, La Crosse, snowshoe hare, trivitattus)

• chikungunya virus

• dengue virus

• equine encephalitis viruses (eastern, Venezuelan, western)

• Powassan virus

• St. Louis encephalitis virus

• yellow fever virus

• Zika virus amebic (free living) infections (Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, Sappinia spp., etc) animal bites anthrax botulism brucellosis (Brucella spp. including B. abortus, B.

canis, B. melitensis, B. suis)

Cronobacter, Invasive (infants under 1 year of age) cholera (toxigenic Vibrio cholerae) diphtheria Haemophilus in�uenzae, invasive infections hantavirus pulmonary syndrome (HPS) hemolytic uremic syndrome (HUS) hepatitis A

• reactive anti-HAV IgM

To be determined in consultation with DPH Epidemiology.

Based on public health impact potential. Ultimate decision made by State Health O�cer and State Epidemiologist.

Invasive isolated from blood, bone, CSF, joint, pericardial, peritoneal, or pleural �uid.

ALT and total bilirubin associated with hepatitis A, B, or C serology should be reported

L. monocytogenes resulting in infant mortality is reportable to Vital Records.

Potential agent of bioterrorism

Health Services Contract Part 9, Attachment 4 hepatitis D (acute and chronic) hepatitis E (acute)

HIV infection#

• Infection, any stage OR progression to stage

3 (AIDS)

• Perinatal HIV exposure in�uenza, RSV, or COVID-19-associated death (all ages) legionellosis leprosy (Hansen’s disease) (Mycobacterium leprae) leptospirosis listeriosis Lyme disease malaria maternal death (during pregnancy or within 1 year of end of pregnancy)### multisystem in�ammatory syndrome in children (MIS-C) mumps psittacosis rubella (including congenital) salmonellosis (including typhoid fever and paratyphoid fever) shigellosis Spotted Fever Rickettsiosis (Rickettsia spp.)

streptococcal disease, group A or B (invasive)

Streptococcus pneumoniae infection (invasive)

• report with antibiotic-resistance information tetanus toxic shock syndrome (TSS) varicella (chickenpox) vibriosis (Vibrio spp.)

yersiniosis

REPORT WITHIN 14 DAYS

Neonatal Abstinence Syndrome (NAS). Information for reporting NAS is available at dph.georgia.gov/nas.

Report cases electronically through the state electronic noti�able disease surveillance system at sendss.state.ga.us acute �accid myelitis (AFM) acquired immunode�ciency syndrome (AIDS)# anaplasmosis aseptic meningitis babesiosis blood lead levels campylobacteriosis Candida auris infections carbapenem-resistant Enterobacterales (CRE) infections

• Enterobacter spp.

• Escherichia coli

• Klebsiella spp.

chancroid Chlamydia trachomatis Infection (including Lymphogranuloma venereum congenital cytomegalovirus, cCMV ( 21 days of age)

Creutzfeldt-Jakob Disease (CJD), con�rmed and suspected cases < 55 years old cryptosporidiosis cyclosporiasis ehrlichiosis giardiasis gonorrhea hearing loss (con�rmed or suspected permanent, <6 years old)## hepatitis B (acute and chronic)

• reactive HBsAg and all associated HBV lab markers

(HBV DNA, anti-HBc IgM, total anti-HBc, anti-HBe, HBeAg, anti-HBs)

• detected HBV DNA and all associated HBV lab markers (HBsAg anti-HBc IgM, total anti-HBc, anti-HBe, HBeAg, anti-HBs)

• undetectable HBV DNA

• HBsAg reactive pregnant women

• perinatal HBV exposures

• all HBsAg and anti-HBs (positive, negative, indeterminate) for children ≤ 2 years old hepatitis C (acute and chronic)

• reactive anti-HCV (both serology and point-of-care rapid testing)

• HCV RNA by PCR (both detected and undetected)

• detected HCV genotype

• anti-HCV reactive or HCV RNA detected pregnant women

• perinatal HCV exposures

• all (positive, negative, indeterminate) anti-HCV and

HCV RNA by PCR for children ≤ 3 years of age

REPORT WITHIN 7 DAYS

REPORT WITHIN 1 MONTH

Birth Defects, including fetal deaths of at least 20 weeks gestational age and children < 6 years old.

Information for reporting birth defects available at dph.georgia.gov/birth-defects-reporting.

Healthcare-associated Infections (HAIs). For facilities required to report HAI data to CMS via NHSN. Report in accordance with the NHSN protocol. Reporting requirements and information available at dph.georgia.gov/epidemiology/healthcare-associated-infections/nhsn-noti�able-reporting.

REPORT WITHIN 6 MONTHS

Benign brain and central nervous system tumors Cancer

Report forms and reporting information for tumors and cancer is available at dph.georgia.gov/chronic-disease-prevention/georgia-comprehensive-cancer-registry/reporting-cancer.

REPORTING FOR OTHER CONDITIONS

Report forms and reporting requirements available at dph.georgia.gov/epidemiology/georgias-hivaids-epidemiology-section/hivaids-case-reporting.

Hearing loss case report form isavailable at dph.georgia.gov/EHDI.

Reporting information for maternal deaths is available at dph.georgia.gov/maternal-mortality.

“Clinical materials” is de�ned as: A. a clinical isolate containing the infectious agent for which submission of material is required;

or B. if an isolate is not available, material containing the infectious agent for which submission of material is required, in the following order of preference: (1) a patient specimen; (2) nucleic acid; or (3) other laboratory material.

“Invasive disease” is de�ned as: isolated from blood, bone, CSF, joint, pericardial, peritoneal, or pleural �uid.

Updated: January 2025